Y

Yamo Pharmaceuticals

6 employees

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company that develops L1-79, a novel therapy for Autism spectrum disorder.

Basic info

Industry

biotechnology research

Sectors

Life Sciences
Biotechnology
Autism
ASD
Pharmaceutical
Drug Development
Biopharmaceuticals

Date founded

2015

Funding rounds raised

Y

Yamo Pharmaceuticals raised undisclosed on November 10, 2021

Investors: Autism Impact Fund

FAQ